Proton Drugs And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1.54%
- Profit Growth 35.69%
- Ebitda 32.13%
- Net Worth 11.69%
- Total Assets 12.39%
About Proton Drugs And Chemicals
Proton Drugs And Chemicals Pvt Ltd (PDACPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 1986 and has a history of 38 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sharad Shah and Kamini Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH1986PTC041635
- Company No.
041635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Proton Drugs And Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Shah  | Director | 21-Nov-1986 | Current |
| Kamini Shah | Director | 01-Apr-2021 | Current |
Financial Performance of Proton Drugs And Chemicals.
Proton Drugs And Chemicals Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 1.54% increase. The company also saw a substantial improvement in profitability, with a 35.69% increase in profit. The company's net worth Soared by an impressive increase of 11.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proton Drugs And Chemicals?
Unlock access to Proton Drugs And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Proton Drugs And Chemicals?
Unlock and access historical data on people associated with Proton Drugs And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proton Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proton Drugs And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
